Springbok Capital Management »

Intercept Pharmaceuticals In shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Intercept Pharmaceuticals In shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Intercept Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 63k 18.54
2021-06-30 $202k 10k 20.00
2021-03-31 $233k 10k 23.07
2020-12-31 $342k 14k 24.73
2020-09-30 $4.0k 100 40.00
2020-06-30 $14k 300 46.67
2019-09-30 $10k 151 66.23
2019-06-30 $12k 154 77.92
2019-03-31 $74k 674 109.20
2018-12-31 $7.0k 73 95.89
2018-09-30 $9.0k 73 123.29
2018-06-30 $1.1M 13k 83.92
2017-09-30 $102k 1.8k 58.15
2017-06-30 $2.1M 18k 121.08
2017-03-31 $165k 1.5k 113.01
2014-12-31 $78k 500 156.00

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Tesla Motors (TSLA)
Activision Blizzard Call Option
Horizon Therapeutics Pub L SHS Call Option
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Consol Energy (CEIX)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Brighthouse Finl (BHF)
Netease Sponsored Ads (NTES)
Bio Rad Labs Cl A (BIO)
Select Sector Spdr Tr Sbi Int-utils Put Option (XLU)
Trip Com Group Ads (TCOM)

View all positions for Springbok Capital Management